Matches in Wikidata for { <http://www.wikidata.org/entity/Q88312666> ?p ?o ?g. }
- Q88312666 description "artículu científicu espublizáu en febreru de 2018" @default.
- Q88312666 description "im Februar 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q88312666 description "scientific article published on 14 February 2018" @default.
- Q88312666 description "wetenschappelijk artikel" @default.
- Q88312666 description "наукова стаття, опублікована 14 лютого 2018" @default.
- Q88312666 name "HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy" @default.
- Q88312666 name "HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy" @default.
- Q88312666 type Item @default.
- Q88312666 label "HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy" @default.
- Q88312666 label "HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy" @default.
- Q88312666 prefLabel "HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy" @default.
- Q88312666 prefLabel "HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy" @default.
- Q88312666 P1433 Q88312666-0B5C430B-FCED-46D6-81CA-2E468D7965A0 @default.
- Q88312666 P1476 Q88312666-4DC472DE-C2AC-4BCA-944A-2F55D7D4C442 @default.
- Q88312666 P2093 Q88312666-035E9FA0-CB03-4024-9849-18D0A018205C @default.
- Q88312666 P2093 Q88312666-068609F9-609B-4015-A79E-26E8F15B795D @default.
- Q88312666 P2093 Q88312666-51ACD9E8-6086-4440-A118-09C8EA70AC54 @default.
- Q88312666 P2093 Q88312666-5F36A8F2-83F7-470B-BBCF-63700C84AD16 @default.
- Q88312666 P2093 Q88312666-C29EB08F-1C36-442A-AD76-FF9C50C2A007 @default.
- Q88312666 P2093 Q88312666-D518E2BB-6E5F-49FF-9773-FF6B4AA25BD9 @default.
- Q88312666 P2093 Q88312666-DAF21459-60A1-48C6-A1B1-7896624FA409 @default.
- Q88312666 P2093 Q88312666-E850252F-0BB7-480B-8627-AB1DE855B785 @default.
- Q88312666 P2093 Q88312666-EB095387-9ECD-41FE-BCF3-2EDB85C7FA65 @default.
- Q88312666 P2860 Q88312666-027467C3-5E26-48E8-89CE-287E96EF029D @default.
- Q88312666 P2860 Q88312666-027F2804-B247-40D0-A423-1FF5FACE7C8B @default.
- Q88312666 P2860 Q88312666-0698B73B-2826-4CAB-A7D3-F60CF1D48BEA @default.
- Q88312666 P2860 Q88312666-0DA10C2A-5744-4CDC-AC1B-15AFE37FA562 @default.
- Q88312666 P2860 Q88312666-0F8B6AAC-D1C0-40D9-9538-B5C5C86232C6 @default.
- Q88312666 P2860 Q88312666-14E40FD0-2AAC-4484-A814-175C4C484630 @default.
- Q88312666 P2860 Q88312666-16A4DE1A-AA09-4809-A140-DD1A07E2DC4A @default.
- Q88312666 P2860 Q88312666-17940CEA-9FDA-4105-A4FC-7B36794D25A9 @default.
- Q88312666 P2860 Q88312666-19915FA0-4244-41F7-8223-431F0BFBF10A @default.
- Q88312666 P2860 Q88312666-1C95F1AF-A678-46C8-9AB1-9AEF56F31457 @default.
- Q88312666 P2860 Q88312666-21958155-8803-4C7E-8FEC-DCC4862804EE @default.
- Q88312666 P2860 Q88312666-2A4AB370-B327-45A1-A07A-1E6111BD3723 @default.
- Q88312666 P2860 Q88312666-3006F264-9BC7-4688-A67B-5C7334E4FBE2 @default.
- Q88312666 P2860 Q88312666-30FFC0EE-D5D8-4B74-842B-60BE1892C5F2 @default.
- Q88312666 P2860 Q88312666-33B35946-B3F8-47BA-A42C-A00877EBE135 @default.
- Q88312666 P2860 Q88312666-3818FCB0-18AB-4FD4-8DDA-431925E6D459 @default.
- Q88312666 P2860 Q88312666-3A7C8650-FFF7-4557-BCBB-7AB14F33DC62 @default.
- Q88312666 P2860 Q88312666-3BAA71FB-4EB4-4B84-ABB6-A86CF68ED050 @default.
- Q88312666 P2860 Q88312666-3BDD8472-F1DB-46EA-B2FA-88CE39E8E6E8 @default.
- Q88312666 P2860 Q88312666-40D8AAA2-47CA-4E23-AA17-6551ECD462F7 @default.
- Q88312666 P2860 Q88312666-422C9493-B207-4525-9BE4-A8E8CA2CA65B @default.
- Q88312666 P2860 Q88312666-45CEFC3E-8DC2-4D60-8ACA-CE882A65EC7A @default.
- Q88312666 P2860 Q88312666-466C6963-AF57-4535-8447-2D71C10BC1DF @default.
- Q88312666 P2860 Q88312666-4F569D3B-6017-43C2-8B57-E6CC38964E69 @default.
- Q88312666 P2860 Q88312666-4FA6B7EC-8A0A-4C9F-B99C-46153EE67603 @default.
- Q88312666 P2860 Q88312666-55A83D8F-DC65-4A2D-86F2-FE24327223CE @default.
- Q88312666 P2860 Q88312666-570A1A71-7F21-40EA-ABE0-6D90B26DC8E3 @default.
- Q88312666 P2860 Q88312666-59CD59E5-6E2D-47F6-94FF-88551F5A1524 @default.
- Q88312666 P2860 Q88312666-5CDB8451-D27B-4D8B-92B4-F0189FE71D42 @default.
- Q88312666 P2860 Q88312666-6661C201-AB83-4625-928D-5001DD3A20C0 @default.
- Q88312666 P2860 Q88312666-6723A089-F7CA-4CEA-A598-D17A96594C97 @default.
- Q88312666 P2860 Q88312666-7188809A-BD8A-4945-972F-C6B04C96A3F3 @default.
- Q88312666 P2860 Q88312666-7A507B5B-6CBA-40FB-B6E3-0AC875BCAAB1 @default.
- Q88312666 P2860 Q88312666-7C66F067-ED2D-400C-861F-88835316BCE4 @default.
- Q88312666 P2860 Q88312666-819E78AD-6597-4AA4-8FB9-C15D2E3FE5B9 @default.
- Q88312666 P2860 Q88312666-878112A4-BFD0-489A-8BBC-BA7AC70F6D43 @default.
- Q88312666 P2860 Q88312666-8BFE9F24-2E3E-4648-BCBB-1E1D5BA5E252 @default.
- Q88312666 P2860 Q88312666-9073601C-53C7-41FF-A5C9-DA4360609626 @default.
- Q88312666 P2860 Q88312666-944FDF31-B128-4062-8E0E-2A50DCB5EE02 @default.
- Q88312666 P2860 Q88312666-99F7B85D-B07F-4B9C-92ED-C23F93E4DBF9 @default.
- Q88312666 P2860 Q88312666-A08F82E5-7785-47EF-887D-707F09E33698 @default.
- Q88312666 P2860 Q88312666-A2AC111F-8201-4277-ACA2-FB3FF1E10C20 @default.
- Q88312666 P2860 Q88312666-AA45053D-B54E-43B9-A7F0-31109FA275E9 @default.
- Q88312666 P2860 Q88312666-AFCF09D8-8A5D-4065-B34A-4713ACBBDC98 @default.
- Q88312666 P2860 Q88312666-B312BD4C-0CEA-41BB-BF1A-101A69E5C11B @default.
- Q88312666 P2860 Q88312666-B61C5993-AF11-4C0E-8B57-AFE658B76C15 @default.
- Q88312666 P2860 Q88312666-B94B086A-C4C1-4247-82F4-B0864FE90F3C @default.
- Q88312666 P2860 Q88312666-BE136321-433C-458B-AEF0-B0C1BD10D51D @default.
- Q88312666 P2860 Q88312666-C68A4319-938C-4FE8-9796-7F7EF92B280C @default.
- Q88312666 P2860 Q88312666-D0632D0D-2B65-49E1-B99F-4A912852D769 @default.
- Q88312666 P2860 Q88312666-E52B323F-6D4A-4D8B-9079-E4C40D37C9BE @default.
- Q88312666 P2860 Q88312666-E67ACC33-B17D-4208-B615-BB7DB28D64EC @default.
- Q88312666 P2860 Q88312666-ED921914-2C42-4532-90CE-985EF31BA2F7 @default.
- Q88312666 P2860 Q88312666-FADAC8A7-5F68-4F39-8443-80AA68682CDE @default.
- Q88312666 P2860 Q88312666-FAE271CB-6889-4444-AB5A-FA9DB0A96314 @default.
- Q88312666 P2860 Q88312666-FB2963AC-FD8F-4384-9898-D69AF15C60A2 @default.
- Q88312666 P2860 Q88312666-FCD7EBF7-5C2A-42EC-978F-FD10098C94AE @default.
- Q88312666 P2860 Q88312666-FFB302BA-6E48-4214-A032-C900B3D9F26F @default.
- Q88312666 P304 Q88312666-3C5E5EC6-0C68-4283-B052-6F95C43A5468 @default.
- Q88312666 P31 Q88312666-E9A45638-83D0-4C85-8279-8807318C92FE @default.
- Q88312666 P356 Q88312666-61A91DF7-1C79-44E9-96F2-8943750F3CCC @default.
- Q88312666 P433 Q88312666-66ECFBEC-4A0C-4EA3-B104-22ECEEAA94C9 @default.
- Q88312666 P478 Q88312666-262EDC1F-4A19-4D56-B433-705A3B83EBF2 @default.
- Q88312666 P50 Q88312666-052AEBB4-4E80-45C5-AB8D-26BA8F73D508 @default.
- Q88312666 P50 Q88312666-0BA0820B-9423-4AC3-A630-1B574339A8C0 @default.
- Q88312666 P50 Q88312666-90C19788-125E-4BB8-A41A-457B79D1E7A9 @default.
- Q88312666 P577 Q88312666-4D3A6FC9-2A1F-4C0E-8511-38A430495B1B @default.
- Q88312666 P698 Q88312666-3AB5B67D-F96C-4349-8EA4-0F76D53D7D31 @default.
- Q88312666 P921 Q88312666-491268B2-2DF2-42C8-8598-2AC9539CCF86 @default.
- Q88312666 P921 Q88312666-AAD2349B-F37A-4B55-A22F-79269E41EDB2 @default.
- Q88312666 P932 Q88312666-0B49029B-AE97-4134-AA46-29E9BBF73117 @default.
- Q88312666 P356 2162402X.2017.1316438 @default.
- Q88312666 P698 29632711 @default.
- Q88312666 P1433 Q18026500 @default.
- Q88312666 P1476 "HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy" @default.
- Q88312666 P2093 "Daniel J Kowalewski" @default.
- Q88312666 P2093 "Heiko Schuster" @default.